Efficacy and Safety Study of Lipid-Lowering Effects of XueZhiKang (XZK) in Patients With Hyperlipidemia
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the efficacy of XueZhiKang to improve plasma
lipid profile, as compared to placebo, in outpatients with hyperlipidemia.